Clever Culture Systems Limited (ASX:CC5)
Australia · Delayed Price · Currency is AUD | Market Cap | 52.25M +64.4% |
| Revenue (ttm) | 5.17M +53.6% |
| Net Income | -744.00K |
| EPS | -0.00 |
| Shares Out | 2.18B |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 100,000 |
| Average Volume | 878,434 |
| Open | 0.0230 |
| Previous Close | 0.0240 |
| Day's Range | 0.0230 - 0.0230 |
| 52-Week Range | 0.0140 - 0.0370 |
| Beta | 1.78 |
| RSI | 52.34 |
| Earnings Date | May 1, 2026 |
About Clever Culture Systems
Clever Culture Systems Limited engages in the research, development, and commercialization of technology solutions for medical industry in Australia, the United States, Sweden, the United Kingdom, China, Netherlands, and Germany. The company offers Automated Plate Assessment System, a solution that automates the imaging, analysis, and interpretation of microbiology culture plates primarily for microbiology laboratories and pharmaceutical manufacturing sector; Digital Microbiology; and APAS modules, an artificial intelligence algorithm that work... [Read more]
Financial Performance
Financial StatementsNews
Clever Culture Systems Earnings Call Transcript: Q3 2026
Partnerships and sales in the global pharma segment drove recurring revenue, with strong cash management and no supply chain disruptions. Two top 20 pharma customers are expected to be added soon, supporting a multi-year growth strategy.
Clever Culture Systems Earnings release: Q3 2026
Clever Culture Systems released its Q3 2026 earnings on April 30, 2026, summarizing the period's financial results.
Clever Culture Systems Quarterly report: H1 2026
Clever Culture Systems has published its H1 2026 quarterly earnings report on February 16, 2026.
Clever Culture Systems Slides: Company presentation
Clever Culture Systems has posted slides in relation to its latest quarterly earnings report, which was published on February 10, 2026.
Clever Culture Systems Earnings release: Q2 2026
Clever Culture Systems released its Q2 2026 earnings on January 27, 2026, summarizing the period's financial results.
Clever Culture Systems Transcript: AGM 2025
The meeting highlighted a return to profitability, major new contracts, and a strengthened balance sheet. Strategic initiatives included expanding the APAS platform and exploring new product development, with a focus on disciplined execution and shareholder value.
Clever Culture Systems Slides: FY 2025
Clever Culture Systems has posted slides in relation to its FY 2025 quarterly earnings report, which was published on November 16, 2025.
Clever Culture Systems Earnings release: Q1 2026
Clever Culture Systems released its Q1 2026 earnings on October 28, 2025, summarizing the period's financial results.
Clever Culture Systems Annual report: H2 2025
Clever Culture Systems has published its H2 2025 annual report on September 15, 2025.
Clever Culture Systems Earnings Call Transcript: Q4 2025
Fiscal 2025 saw a breakthrough with APAS Independence gaining traction among top-tier pharmaceutical customers, driving financial stability and a robust sales pipeline. Major upgrades and new customer evaluations position the company for further growth in the expanding automation market.
Clever Culture Systems Earnings release: Q4 2025
Clever Culture Systems released its Q4 2025 earnings on August 3, 2025, summarizing the period's financial results.
Clever Culture Systems Slides: Corporate Presentation
Clever Culture Systems has posted slides in relation to its latest quarterly earnings report, which was published on June 24, 2025.
Clever Culture Systems Earnings Call Transcript: Q3 2025
Second consecutive quarter of cash flow positive operations, with a robust sales pipeline and key validations from major pharmaceutical partners. Outlook remains strong for fiscal 2025, supported by expanded marketing, ongoing technology validation, and favorable industry trends.
Clever Culture Systems Earnings release: Q3 2025
Clever Culture Systems released its Q3 2025 earnings on May 12, 2025, summarizing the period's financial results.
Clever Culture Systems Quarterly report: H1 2025
Clever Culture Systems has published its H1 2025 quarterly earnings report on February 19, 2025.
Clever Culture Systems Earnings Call Transcript: Q2 2025
Sales growth in 2024 was driven by major pharma clients, with AstraZeneca validating and rolling out APAS technology. Cash flows are expected to remain break-even or better, supported by strong gross margins and a growing sales pipeline.
Clever Culture Systems Earnings release: Q2 2025
Clever Culture Systems released its Q2 2025 earnings on February 4, 2025, summarizing the period's financial results.
Clever Culture Systems Transcript: AGM 2024
The meeting highlighted a successful strategic pivot to pharmaceutical environmental monitoring, strong financial progress with new capital and major sales, and a restructured board. Key resolutions included director elections, incentive plans, and a company name change, with all votes conducted by poll.
Clever Culture Systems Slides: FY 2024
Clever Culture Systems has posted slides in relation to its FY 2024 quarterly earnings report, which was published on November 13, 2024.
Clever Culture Systems Earnings Call Transcript: Q1 2025
Record sales and major contracts with AstraZeneca and BMS drove strong commercial momentum and positive cash flow outlook. Over AUD 4.4 million in committed inflows support expectations for positive net operating and investing cash flows in the next two quarters.
Clever Culture Systems Earnings release: Q1 2025
Clever Culture Systems released its Q1 2025 earnings on October 30, 2024, summarizing the period's financial results.
Clever Culture Systems Annual report: H2 2024
Clever Culture Systems has published its H2 2024 annual report on August 29, 2024.
Clever Culture Systems Slides: Investor Presentation
Clever Culture Systems has posted slides in relation to its latest quarterly earnings report, which was published on August 18, 2024.
Clever Culture Systems Earnings Call Transcript: Q4 2024
Strong sales momentum with major pharmaceutical clients, highlighted by a significant AstraZeneca contract and record instrument shipments expected in H1 FY2025. Cash position remains stable, with further inflows anticipated and expanded market engagement underway.
Clever Culture Systems Earnings release: Q4 2024
Clever Culture Systems released its Q4 2024 earnings on August 13, 2024, summarizing the period's financial results.